Data Characteristics for This Category
Phase I clinical study data originates primarily from study protocols, subject screening records, informed consent forms, case report forms (CRFs), adverse event (AE) reports, laboratory test results, imaging reports, ECG data, and pharmacokinetic (PK) and pharmacodynamic (PD) data. This data typically exists as a mix of structured tables (e.g., CSV, Excel), semi-structured documents (e.g., PDF reports), and unstructured text (e.g., investigator notes). Data update frequency is high during the study, with timely entry after each visit or event. Document structures are rigorous, adhering to GCP guidelines, and contain extensive specialized terminology, abbreviations, and units of measurement, such as dosage (mg/kg), concentration (ng/mL), time points (hours, days), and various biomarker indicators.
Constraints Imposed by These Characteristics on "Model Integration and Configuration"
The rigor and specialized nature of Phase I clinical data require the model to accurately identify and process domain-specific terminology and units during understanding and generation, avoiding misinterpretation or confusion. The diversity of data sources (structured and unstructured coexistence) necessitates support for various file format parsing and extraction capabilities. High update frequency demands real-time synchronization and incremental updates for the knowledge base, ensuring the model always responds based on the latest data. The strict document structure and numerous specialized fields make the selection of context window length and segmentation strategy crucial to ensure key information is not truncated and the model can effectively capture relationships between information. Additionally, for sensitive clinical data, model integration must consider data privacy and compliance, potentially requiring private model deployment or data anonymization.
How to Determine Configuration
| Configuration Item | Suggested Value | Rationale for This Value |
|---|---|---|
maxContext | 32000 tokens | Phase I clinical documents are content-rich; the model needs to cover a sufficiently long context to capture key information like drug interactions, adverse events, and dosage correlations. |
Chunk size | 800–1200 characters | Balances the completeness of single-segment information with model processing efficiency, preventing key information from being split, while reducing redundancy. |
Chunk Overlap Length | 100–200 characters | Ensures sufficient contextual overlap between adjacent segments, improving retrieval relevance. |
Recall count | Top 5 entries | Phase I clinical questions often require multiple supporting facts; increasing the number of recalled items enhances the comprehensiveness of the answer. |
Similarity threshold | Calibrated by actual measurement | Based on specific corpus and model evaluation, ensures highly relevant documents are recalled and low-relevance noise is excluded. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Phase I clinical reports (e.g., detailed PK/PD reports) can be large files with longer parsing times; increasing the timeout prevents parsing failures. |
Three Common Pitfalls
- No available text understanding models in the dropdown when creating a knowledge base. This happens when text understanding models added in the model channel (e.g., BGE-M3) are not configured correctly or their services are not running properly.
- After connecting a local DeepSeek model, the chat interface automatically switches to a GPT model. This occurs when the local model is not correctly recognized as an available model, or the routing strategy is misconfigured, causing requests to be redirected.
- After uploading a large PDF report, file parsing fails or content is incomplete. This manifests as parsing progress stagnation or an empty knowledge base. The
PARSE_FILE_TIMEOUT_SECONDSparameter may be too short, causing the file to not complete parsing within the allotted time.
How to Confirm Correct Configuration
- Upload a typical Phase I clinical study report PDF. Check if segments have been successfully generated in the knowledge base and verify the completeness and accuracy of the segment content.
- Ask questions about specific technical terms and data points from the report. Verify if the model can correctly understand and recall relevant segments from the knowledge base.
- Simulate complex questions about drug dosage, adverse events, or pharmacokinetic parameters. Evaluate if the model's answers are accurate, consistent, and cite correct source information.
- Check system logs to confirm no abnormal errors or timeout records occurred during file parsing and model invocation.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.